Author Login

Correspondence to Author:  Marie Peraira and Gebrela Santos-Gomes. 

Student Research Center, Faculty of Medicine, Tarbiat Modares University, Tehran, Iran.

Introduction:  Animal and human infectious parasite illnesses continue to be a major global health concern. Protozoan-caused parasitic diseases are linked to significant health expenditures for both humans and animals as well as direct and indirect financial loss. The main human protozoan parasite illnesses, which result in 82.4 million Disability Adjusted Life Years and 810,000 fatal cases annually, are predicted to have a prevalence of about 790 million individual cases, according to [1]. The majority of protozoan parasitic diseases are linked to economically disadvantaged populations [1], unsanitary water supplies and conditions [2], and host immunodeficiency [3]. These diseases are frequently spread by vectors (vector-borne diseases), contaminated food (food-borne diseases), or water (water-borne diseases). An integrative and multidisciplinary strategy is necessary for the control and prevention of these protozoan parasites because many of them are zoonotic [4]. Leishmania spp., Trypanosoma brucei, Toxoplasma gondii, Plasmodium falciparum, Giardia duodenalis, Cryptosporidium parvum protozoan parasites, and Rhipicephalus bursa, a multi host hard tick that spreads several economically significant pathogens in ruminants, such as Babesia, Anaplasma, Theileria, Rickettsia, and Coxiella, as well as several zoonotic pathogens, are all covered in the nine research papers in this Special Issue of Biomedicines (MDPI), “Parasitic Infection and Immunity” [5]. These studies fall into three major categories: vaccine and therapeutic development, protozoan parasitic immunology, and novel biological characteristics of protozoan parasites.

Citation:

Marie Peraira. An Issue Particular To Biomedicines: Parasitic Infection And Immunity. Advances in Tropical Medicine 2025.